Director at Hanover Bancorp (HNVR) receives 1,592 restricted stock shares

Rhea-AI Filing Summary

Hanover Bancorp, Inc. director Metin Negrin received a grant of 1,592 shares of common stock on February 5, 2026. The grant is in the form of restricted stock subject to forfeiture.

The restricted shares vest over three years, with one-third vesting on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. Following this award, Negrin directly beneficially owns 238,647 shares of Hanover Bancorp common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Negrin Metin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,592	$0.00	--

Holdings After Transaction: Common Stock — 238,647 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Negrin Metin

(Last) (First) (Middle)

C/O HANOVER BANCORP, INC.

80 EAST JERICHO TURNPIKE

(Street)

MINEOLA NY 11501

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hanover Bancorp, Inc. /MD [ HNVR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/05/2026		A		1,592(1)	A	$0.0000	238,647	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of restricted stock subject to forfeiture, vesting over a three year period, with 1/3 vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029.

	/s/ Metin Negrin	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hanover Bancorp (HNVR) disclose for Metin Negrin?

Hanover Bancorp disclosed that director Metin Negrin received a grant of 1,592 shares of common stock as restricted stock. This award increased his directly held beneficial ownership to 238,647 shares of Hanover Bancorp common stock.

When does Metin Negrin’s restricted stock grant in Hanover Bancorp (HNVR) vest?

The 1,592 restricted shares granted to Metin Negrin vest over three years. One-third vests on March 1, 2027, another third on March 1, 2028, and the final third on March 1, 2029, subject to forfeiture conditions.

How many Hanover Bancorp (HNVR) shares does Metin Negrin own after the reported grant?

After the reported grant, director Metin Negrin beneficially owns 238,647 shares of Hanover Bancorp common stock. This figure reflects his directly held position following the award of 1,592 restricted shares on February 5, 2026.

What type of security was granted to Metin Negrin in the Hanover Bancorp (HNVR) Form 4?

The Form 4 shows a grant of common stock in the form of restricted shares to director Metin Negrin. These shares are subject to forfeiture and vest in three equal installments from 2027 through 2029.

At what price were the Hanover Bancorp (HNVR) restricted shares granted to Metin Negrin?

The 1,592 restricted shares of Hanover Bancorp common stock granted to Metin Negrin were reported at a transaction price of $0.0000 per share, consistent with a compensatory equity award rather than an open-market purchase.